Literature DB >> 22972545

Molecular studies on the roles of Runx2 and Twist1 in regulating FGF signaling.

Yongbo Lu1, Yucheng Li, Adriana C Cavender, Suzhen Wang, Alka Mansukhani, Rena N D'Souza.   

Abstract

BACKGROUND: Supernumerary teeth are often observed in patients suffering from cleidocranial dysplasia due to a mutation in Runx2 that results in haploinsufficiency. However, the underlying molecular mechanisms are poorly defined. In this study, we assessed the roles of Runx2 and its functional antagonist Twist1 in regulating fibroblast growth factor (FGF) signaling using in vitro biochemical approaches.
RESULTS: We showed that Twist1 stimulated Fgfr2 and Fgf10 expression in a mesenchymal cell line and that it formed heterodimers with ubiquitously expressed E12 (together with E47 encoded by E2A gene) and upregulated Fgfr2 and Fgf10 promoter activities in a dental mesenchyme-derived cell line. We further demonstrated that the bHLH domain of Twist1 was essential for its synergistic activation of Fgfr2 promoter with E12 and that the binding of E12 stabilized Twist1 by preventing it from undergoing lysosomal degradation. Although Runx2 had no apparent effects on Fgfr2 and Fgf10 promoter activities, it inhibited the stimulatory activity of Twist1 on Fgfr2 promoter.
CONCLUSIONS: These findings suggest that Runx2 haploinsufficiency might result in excessive unbound Twist1 that can freely bind to E12 and enhance FGF signaling, thereby promoting the formation of extra teeth.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22972545      PMCID: PMC4153435          DOI: 10.1002/dvdy.23858

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  47 in total

1.  Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development.

Authors:  Takashi Yamashiro; Thomas Aberg; Ditsa Levanon; Yoram Groner; Irma Thesleff
Journal:  Mech Dev       Date:  2002-12       Impact factor: 1.882

2.  Receptor specificity of the fibroblast growth factor family.

Authors:  D M Ornitz; J Xu; J S Colvin; D G McEwen; C A MacArthur; F Coulier; G Gao; M Goldfarb
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

3.  Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation.

Authors:  P Ducy; R Zhang; V Geoffroy; A L Ridall; G Karsenty
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

Review 4.  Structure and function of helix-loop-helix proteins.

Authors:  C Murre; G Bain; M A van Dijk; I Engel; B A Furnari; M E Massari; J R Matthews; M W Quong; R R Rivera; M H Stuiver
Journal:  Biochim Biophys Acta       Date:  1994-06-21

Review 5.  Saethre-Chotzen syndrome.

Authors:  W Reardon; R M Winter
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

6.  Mutations of the TWIST gene in the Saethre-Chotzen syndrome.

Authors:  V el Ghouzzi; M Le Merrer; F Perrin-Schmitt; E Lajeunie; P Benit; D Renier; P Bourgeois; A L Bolcato-Bellemin; A Munnich; J Bonaventure
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

7.  Fibroblast growth factor receptors 1 and 2 are differentially regulated in murine embryonal carcinoma cells and in response to fibroblast growth factor-4.

Authors:  J Ali; A Mansukhani; C Basilico
Journal:  J Cell Physiol       Date:  1995-11       Impact factor: 6.384

8.  An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers.

Authors:  X H Sun; D Baltimore
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

9.  Development of the dentition in cleidocranial dysplasia.

Authors:  B L Jensen; S Kreiborg
Journal:  J Oral Pathol Med       Date:  1990-02       Impact factor: 4.253

10.  A twist code determines the onset of osteoblast differentiation.

Authors:  Peter Bialek; Britt Kern; Xiangli Yang; Marijke Schrock; Drazen Sosic; Nancy Hong; Hua Wu; Kai Yu; David M Ornitz; Eric N Olson; Monica J Justice; Gerard Karsenty
Journal:  Dev Cell       Date:  2004-03       Impact factor: 12.270

View more
  8 in total

Review 1.  Genetic factors contributing to skeletal class III malocclusion: a systematic review and meta-analysis.

Authors:  Alexandra Dehesa-Santos; Paula Iber-Diaz; Alejandro Iglesias-Linares
Journal:  Clin Oral Investig       Date:  2021-02-07       Impact factor: 3.573

2.  Twist1 Is Essential for Tooth Morphogenesis and Odontoblast Differentiation.

Authors:  Tian Meng; Yanyu Huang; Suzhen Wang; Hua Zhang; Paul C Dechow; Xiaofang Wang; Chunlin Qin; Bing Shi; Rena N D'Souza; Yongbo Lu
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

Review 3.  The epidemiology of supernumerary teeth and the associated molecular mechanism.

Authors:  Xi Lu; Fang Yu; Junjun Liu; Wenping Cai; Yumei Zhao; Shouliang Zhao; Shangfeng Liu
Journal:  Organogenesis       Date:  2017-06-09       Impact factor: 2.500

4.  The role of TWIST, SERPINB5, and SERPIN1 genes in uterine leiomyomas.

Authors:  Mehmet Sühha Bostancı; Merih Bayram; Süleyman Murat Bakacak; Ozge Kızılkale Yıldırım; Rukset Attar; Gazi Yıldırım; Emin Ümit Bağrıaçık; Baran Celtemen
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-06-01

Review 5.  Functionalized scaffolds to control dental pulp stem cell fate.

Authors:  Evandro Piva; Adriana F Silva; Jacques E Nör
Journal:  J Endod       Date:  2014-04       Impact factor: 4.171

6.  Twist1- and Twist2-haploinsufficiency results in reduced bone formation.

Authors:  Yanyu Huang; Tian Meng; Suzhen Wang; Hua Zhang; Gabriele Mues; Chunlin Qin; Jian Q Feng; Rena N D'Souza; Yongbo Lu
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

7.  A novel, complex RUNX2 gene mutation causes cleidocranial dysplasia.

Authors:  Wen'an Xu; Qiuyue Chen; Cuixian Liu; Jiajing Chen; Fu Xiong; Buling Wu
Journal:  BMC Med Genet       Date:  2017-02-07       Impact factor: 2.103

Review 8.  The Role of Fibroblast Growth Factors in Tooth Development and Incisor Renewal.

Authors:  Wen Du; Wei Du; Haiyang Yu
Journal:  Stem Cells Int       Date:  2018-03-11       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.